Literature DB >> 11773581

Increased prevalence of mutations in the cystic fibrosis transmembrane conductance regulator in children with chronic rhinosinusitis.

Vidya Raman1, Randall Clary, Karen L Siegrist, Barbara Zehnbauer, Talal A Chatila.   

Abstract

OBJECTIVE: Chronic rhinosinusitis results in significant morbidity in the pediatric population; however, no predisposing factor is found in many cases. Cystic fibrosis (CF) is a recognized cause of chronic rhinosinusitis. Although the carrier frequency for CF ranges from 3% to 4% in the general white population, the prevalence of mutations in the CF transmembrane conductance regulator (CFTR) among children with chronic rhinosinusitis is unknown. Our objective was to study the frequency of CFTR mutations among children with chronic rhinosinusitis.
METHODS: Fifty-eight white children who were from the St Louis metropolitan area and had chronic rhinosinusitis, none of whom satisfied diagnostic criteria for CF, underwent sweat testing and genotyping for CFTR mutations using an assay that detects 90% of mutations seen in this ethnic group.
RESULTS: Seven of the 58 patients (12.1%) tested harbored CFTR mutations as compared with the expected rate of 3% to 4% in this ethnic group. Five patients had the DeltaF508, 1 had the R117H, and 1 had the I148T mutation. Only 1 of the 7 children had a borderline abnormal sweat test. Two of the 58 patients experienced recurrent Pseudomonas aeruginosa rhinosinusitis, and both were DeltaF508 heterozygotes. Three other children with no detectable CFTR mutation had borderline elevated sweat-test results. The CFTR intron 8 5T polymorphism was found at a frequency comparable to that reported for the general population.
CONCLUSION: There is an increased occurrence of CFTR mutations in children who have chronic rhinosinusitis and do not meet diagnostic criteria for CF, usually in the setting of a normal sweat chloride. These results suggest a role for CFTR mutations in predisposition to chronic rhinosinusitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773581     DOI: 10.1542/peds.109.1.e13

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  23 in total

1.  Proposal of a CT scoring system of the paranasal sinuses in diagnosing cystic fibrosis.

Authors:  H B Eggesbø; S Søvik; S Dølvik; K Eiklid; F Kolmannskog
Journal:  Eur Radiol       Date:  2003-04-05       Impact factor: 5.315

Review 2.  Radiological imaging of inflammatory lesions in the nasal cavity and paranasal sinuses.

Authors:  H B Eggesbø
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

3.  Low abundance of sweat duct Cl- channel CFTR in both healthy and cystic fibrosis athletes with exceptionally salty sweat during exercise.

Authors:  Mary Beth Brown; Karla K V Haack; Brian P Pollack; Mindy Millard-Stafford; Nael A McCarty
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-01-12       Impact factor: 3.619

Review 4.  Cystic fibrosis chronic rhinosinusitis: a comprehensive review.

Authors:  Mohamad R Chaaban; Alexandra Kejner; Steven M Rowe; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2013 Sep-Oct       Impact factor: 2.467

5.  Prevalence of and associations with allergic rhinitis in children with chronic rhinosinusitis.

Authors:  Ahmad R Sedaghat; Wanda Phipatanakul; Michael J Cunningham
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2013-12-17       Impact factor: 1.675

Review 6.  Genetics of chronic rhinosinusitis: state of the field and directions forward.

Authors:  Joy Hsu; Pedro C Avila; Robert C Kern; M Geoffrey Hayes; Robert P Schleimer; Jayant M Pinto
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

7.  Prevalence of rhinosinusitis among atypical cystic fibrosis patients.

Authors:  Tal Marshak; Y Rivlin; L Bentur; O Ronen; N Uri
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-15       Impact factor: 2.503

Review 8.  Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

Authors:  C Castellani; H Cuppens; M Macek; J J Cassiman; E Kerem; P Durie; E Tullis; B M Assael; C Bombieri; A Brown; T Casals; M Claustres; G R Cutting; E Dequeker; J Dodge; I Doull; P Farrell; C Ferec; E Girodon; M Johannesson; B Kerem; M Knowles; A Munck; P F Pignatti; D Radojkovic; P Rizzotti; M Schwarz; M Stuhrmann; M Tzetis; J Zielenski; J S Elborn
Journal:  J Cyst Fibros       Date:  2008-05       Impact factor: 5.482

Review 9.  Atypical cystic fibrosis and CFTR-related diseases.

Authors:  Shruti M Paranjape; Pamela L Zeitlin
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

10.  A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.

Authors:  Eric T Weimer; Haiping Lu; Nancy D Kock; Daniel J Wozniak; Steven B Mizel
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.